Scoop has an Ethical Paywall
Statement of Preliminary Issues released for GSK application
The Commerce Commission has published a statement of preliminary issues relating to an application from GlaxoSmithKline plc seeking clearance to acquire the consumer healthcare business of Pfizer Inc.
The statement outlines the key competition issues that the Commission considers important in deciding whether or not to grant clearance to the proposed acquisition.
The Commission invites interested parties to provide comments on the likely competitive effects of the proposed acquisition. Submissions can be sent by email to registrar@comcom.govt.nz with the reference GSK/Pfizer in the subject line. Parties should provide a public version of their submission at the same time for publication on the Commission’s case register. Any submissions should be received by close of business on Wednesday 3 April 2019.
The Commission is currently
scheduled to make a decision on the application by 7 May
2019. However, this date may be extended as the
investigation progresses.
The Statement of Preliminary
Issues and a public version of the application can be found
on the on the Commission’s case
register.
SolarZero Affected Staff: SolarZero Staff Are Demanding Answers After The Company Went Into Liquidation
Tātau Tātau O Te Wairoa: Guidance To Save Local Newspapers Amid NZME Closures
Commerce Commission: Systemic Breaches Of Consumer Law Lead To $1.5million Fine For Kiwibank
SolarZero: SolarZero Limited (in Liquidation) - Important Business Update
Science Media Centre: Cyclone Gabrielle's Impacts On NZ's Ecosystems - Expert Reaction
RNZ: Parts Of Power System Could Be Out For 36 Hours In Event Of Extreme Solar Storm
